Global Stem Cells Group is expanding its international presence through a new strategic partnership with Exomagic in Tajikistan. The collaboration aims to support the development of regenerative medicine in Central Asia by connecting international physician education, biotechnology products, and regional medical professionals through ISSCA and Cellgenic.
The partnership brings together GSCG’s international physician education platform and biotechnology product portfolio with Exomagic’s regional relationships and market development activities. The collaboration will initially focus on Tajikistan, with plans to engage healthcare professionals and organizations across neighboring Central Asian countries.
The initiative follows RMTG’s international operating model, which connects physician education, professional training, and product commercialization through its Global Stem Cells Group divisions.
Cellgenic: Establishing a Biotechnology Presence in Central Asia
Cellgenic, the biotechnology and product-commercialization division of Global Stem Cells Group, will work alongside Exomagic to develop local commercial relationships, physician engagement, and distribution infrastructure in the region.
Cellgenic’s portfolio includes exosomes, peptides, cellular products, and related biotechnology offerings for professional markets.
The partnership will focus on product education, commercial training, technical resources, and the development of local support capabilities for healthcare professionals.
The companies intend to coordinate regional distribution activities in accordance with applicable regulatory requirements and local market conditions.
ISSCA: Bringing International Regenerative Medicine Education to Central Asia
The International Society for Stem Cell Application (ISSCA), the education and innovation division of Global Stem Cells Group, will collaborate with Exomagic to introduce its physician education programs to Central Asia.
As part of the partnership, the organizations plan to host an international regenerative medicine conference in Dushanbe, Tajikistan, bringing together physicians, healthcare professionals, researchers, and regional medical organizations.
The proposed educational program will address regenerative medicine, cellular technologies, exosome science, peptide medicine, longevity, and regenerative aesthetics.
The collaboration also includes plans for continuing professional education through specialized workshops, physician training programs, and regional educational activities. ISSCA’s participation will provide an academic component to the partnership, complementing Cellgenic’s regional commercial development.
Management Commentary
Benito Novas, Founder of Global Stem Cells Group, commented:
“We are very happy to begin this new partnership in Central Asia. Our mission has always been to make regenerative medicine knowledge and technologies more accessible to doctors and, ultimately, to the patients they serve. Through ISSCA and Cellgenic, we can bring together education, professional support, and access to biotechnology products. We look forward to working with our partners in Tajikistan and building long-term relationships with the medical community throughout the region.”
Operational and Strategic Update
The Central Asia partnership represents an additional geographic initiative within RMTG’s international activities, complementing the Company’s existing education and commercial programs in Latin America and other international markets.
The collaboration is structured around two complementary operating divisions: ISSCA, focused on physician education and training, and Cellgenic, focused on biotechnology products and commercial relationships.
The Company intends to work with Exomagic on regional implementation, including educational programming, commercial team training, and distribution planning. The timing and scope of individual activities will depend on local arrangements, operational readiness, and applicable regulatory requirements.
The Company is not providing revenue projections or financial guidance associated with this partnership.
Looking Ahead: Advancing Regenerative Medicine in Central Asia
Through this strategic partnership, Global Stem Cells Group, ISSCA, Cellgenic, and Exomagic aim to strengthen connections with the medical community in Tajikistan and neighboring countries, supporting future opportunities for physician education, scientific exchange, and biotechnology development.
Healthcare professionals, medical organizations, and potential regional partners interested in learning more about upcoming educational initiatives and collaboration opportunities are invited to visit www.RMTG.com or contact Global Stem Cells Group for further information.
